CUSIP 28036F105COMEWTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
196 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 15.52M | $385.09M | 0 | Held |
| 2 | Ra Capital Management, L.P. | 10.43M | $258.78M | 0 | Held |
| 3 | Blackrock, Inc. | 6.63M | $164.54M | +279.1K | Added |
| 4 | Baker Bros. Advisors LP | 6.58M | $163.18M |
| −730.0K |
| Reduced |
| 5 | Paradigm Biocapital Advisors LP | 6.54M | $162.32M | +371.1K | Added |
| 6 | Novo Holdings A/S | 5.35M | $132.76M | 0 | Held |
| 7 | Braidwell LP | 5.21M | $129.31M | 0 | Held |
| 8 | Vanguard Group Inc | 4.87M | $120.89M | +67.7K | Added |
| 9 | Janus Henderson Group PLC | 4.57M | $113.33M | −412.5K | Reduced |
| 10 | Siren, L.L.C. | 4.53M | $112.41M | +632.9K | Added |
See every fund holding Edgewise Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders